Saturday, November 2, 2024
Facebook Linkedin Twitter
HomeTagsHorizon Therapeutics

Horizon Therapeutics

Biotechnology

Horizon Therapeutics plc Announces Initiation of Phase 3 Clinical Trial in Japan Evaluating TEPEZZA in Adults with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye...

Business Wire -
Horizon Therapeutics plc announced that the first patient has been enrolled in a Phase 3 clinical trial in Japan evaluating TEPEZZA for the treatment...
Biotechnology

Horizon Therapeutics plc Announces Positive Topline Data from TEPEZZA Phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score, Thyroid Eye Disease

News Desk -
Horizon Therapeutics plc announced positive and statistically significant topline results from its randomized, double-masked, placebo-controlled Phase 4 clinical trial evaluating TEPEZZA for the treatment of...
Food & Beverage

Horizon Therapeutics plc Partners with Christine Ha

Business Wire -
Horizon Therapeutics plc is teaming up with Christine Ha, the first blind contestant on MasterChef and winner of the show’s third season, who has...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us